![Felipe Duran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Felipe Duran
Finanzdirektor/CFO bei
IBIO, INC.
Vermögen: 68 351 $ am 31.05.2026
Profil
Felipe Duran is currently Chief Financial Officer at iBio, Inc. since 2023.
Formerly, Mr. Duran was Chief Financial Officer-Lupin Latin America at Lupin Pharmaceuticals, Inc. from 2016 to 2021 and Manager-Financial Planning & Analysis at Noven Pharmaceuticals, Inc. Education includes undergraduate and MBA degrees from the University of Miami.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IBIO, INC. 0,1 % | 19.03.2026 | 35.974 ( 0,1 % ) | 68 351 $ | 31.05.2026 |
Aktive Positionen von Felipe Duran
| Unternehmen | Position | Beginn |
|---|---|---|
| IBIO, INC. | Finanzdirektor/CFO | 13.02.2023 |
Ehemalige bekannte Positionen von Felipe Duran
| Unternehmen | Position | Ende |
|---|---|---|
Lupin Pharmaceuticals, Inc.
 Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Finanzdirektor/CFO | 01.05.2021 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Felipe Duran
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes generic formulations, biotechnology products & APIs | Health Technology |
